Oral Incretin-Based Therapies for Weight Management

More on GLP1R

• Lancet·4 Oct 2026

  Orforglipron matches insulin glargine on cardiovascular safety

  

• The New England Journal of Medicine·4 Oct 2026

  Survodutide reduces weight in adults with diabetes and obesity

  

• Cell Metabolism·8 Oct 2026

  A triple-target drug cut body weight by up to 19.7% in a trial

  

• The New England Journal of Medicine·4 Oct 2026

  Retatrutide reduces weight and pain in adults with obesity